Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.950
+0.160 (8.94%)
At close: Aug 13, 2025, 4:00 PM
1.870
-0.080 (-4.10%)
Pre-market: Aug 14, 2025, 9:01 AM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $181.59 million as of August 14, 2025. Its market cap has decreased by -14.81% in one year.
Market Cap
181.59M
Enterprise Value
23.49M
1-Year Change
-14.81%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $181.59M, a decrease of -79.56%. That is a compound annual growth rate of -32.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 181.59M | 26.12% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |